• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Turning Point Brands Announces Fourth Quarter and Full Year 2023 Results

    2/28/24 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary
    Get the next $TPB alert in real time by email

    -Net Sales for Q4 2023 Zig-Zag and Stoker's Products Increased 5.9 Percent Year-Over-Year

    -Adjusted EBITDA for Q4 2023 of $24.8 Million Increased 7.5 Percent Year-Over-Year

    -FY 2023 Free Cash Flow of $61.2 Million

    Turning Point Brands, Inc. ("TPB" or "the Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today financial results for the fourth quarter and full year ended December 31, 2023.

    Q4 2023 vs. Q4 2022

    • Total consolidated net sales decreased 6.1% to $97.1 million
      • Zig-Zag Products net sales decreased by 2.9%
      • Stoker's Products net sales increased by 18.6%
      • Creative Distribution Solutions net sales decreased by 43.7%
    • Gross profit increased 1.9% to $50.5 million
    • Net income increased $26.4 million to $10.1 million
    • Adjusted net income increased 15.9% to $15.3 million (see Schedule B for a reconciliation to net income)
    • Adjusted EBITDA increased 7.5% to $24.8 million (see Schedule A for a reconciliation to net income)
    • Diluted EPS of $0.53 and Adjusted Diluted EPS of $0.79 compared to $(0.93) and $0.69 in the same period one year ago, respectively (see Schedule B for a reconciliation to Diluted EPS)

    FY 2023 vs. FY 2022

    • Total consolidated net sales decreased 2.3% to $405.4 million
      • Zig-Zag Products net sales decreased by 5.2%
      • Stoker's Products net sales increased by 10.5%
      • Creative Distribution Solutions net sales decreased by 14.3%
    • Gross profit decreased 1.1% to $203.2 million
    • Net income increased 230.4% to $38.5 million
    • Adjusted net income increased 1.1% to $56.8 million (see Schedule B for a reconciliation to net income)
    • Adjusted EBITDA decreased 2.4% to $95.3 million (see Schedule A for a reconciliation to net income)
    • Diluted EPS of $2.01 and Adjusted Diluted EPS of $2.91 compared to $0.64 and $2.83 in the same period one year ago, respectively (see Schedule B for a reconciliation to Diluted EPS)

    Graham Purdy, President and CEO, commented: "Our fourth quarter results were at the high-end of our expectations. The Zig-Zag segment was stable from the previous year excluding the impact of a discontinued product line and is well positioned to return to growth in 2024. Stoker's had an outstanding quarter posting its highest growth rate in over four years led by double-digit growth year-over-year in Stoker's MST. We also had strong free cash flow generation during the year allowing us to build a cash balance to address the remaining principal amount of our convertible notes at maturity in July. Our outlook for 2024 is positive as we expect solid growth in our Zig-Zag and Stoker's Products businesses."

    Zig-Zag Products Segment (46% of total net sales in the quarter)

    For the fourth quarter, Zig-Zag Products net sales decreased 2.9% to $45.1 million due to the discontinuation of an unprofitable product line in Canada that impacted sales by $1.4 million.

    For the quarter, the Zig-Zag Products segment gross profit decreased 1.0% to $25.5 million. Gross margin increased 100 basis points to 56.5% driven by product mix.

    For the full year, net sales of Zig-Zag Products decreased 5.2% to $180.5 million due to the reduction of trade inventory earlier in the year and the discontinuation of an unprofitable product line in Canada that impacted sales by $4.9 million.

    For the full year, Zig-Zag Products segment gross profit decreased 5.2% to $101.1 million. Gross margin was steady at 56.0%.

    "Our US Zig-Zag papers and alternative channel business posted a strong quarter with double-digit growth to close the year," said Purdy. "With the reduction of trade inventory through the year, Zig-Zag is now positioned to return to growth aided by industry secular growth trends and internal growth initiatives."

    Stoker's Products Segment (39% of total net sales in the quarter)

    For the fourth quarter, Stoker's Products net sales increased 18.6% to $38.0 million on double-digit growth of MST and high-single-digit growth of loose-leaf. For the fourth quarter, total Stoker's Products segment volume increased 14.2%, while price / mix increased 4.4%.

    For the quarter, the Stoker's Products segment gross profit increased 27.2% to $21.9 million. Gross margin expanded 380 basis points to 57.6% due to MST pricing gains and operating leverage.

    For the full year, net sales of Stoker's Products increased 10.5% to $144.6 million on double-digit growth of MST and low-single-digit growth of loose-leaf. For the full year, total Stoker's Products segment volume increased 4.2%, while price / mix increased 6.3%.

    For the full year, the Stoker's Products segment gross profit increased 14.9% to $81.9 million. Gross margin increased 210 basis points to 56.6% due to MST pricing gains.

    "Stoker's had an exceptional quarter with strong market share gains in both the MST and loose-leaf categories as its value proposition continues to resonate with consumers," continued Purdy. "We are excited about the planned expansion of our FRĒ white nicotine pouch product throughout the year."

    Performance Measures in the Fourth Quarter

    Fourth quarter consolidated selling, general and administrative ("SG&A") expenses were $30.9 million compared to $31.2 million in the fourth quarter of 2022.

    Fourth quarter SG&A included the following notable items:

    • $1.9 million of stock options, restricted stock and incentive expense compared to $1.2 million in the year-ago period
    • $1.0 million of FDA PMTA-related expenses for modern oral products compared to $0.3 million in the year-ago period
    • $0.2 million of restructuring costs compared to $1.8 million in the year-ago period
    • $0.1 million of ERP / CRM duplicative system costs compared to $0.3 million of ERP / CRM scoping expenses in the year-ago period

    Total gross debt as of December 31, 2023 was $368.5 million. Net debt (total gross debt less unrestricted cash) at December 31, 2023 was $250.7 million. The Company ended the quarter with total liquidity of $177.9 million, comprised of $117.9 million in cash and $60.0 million of revolving credit facility capacity.

    During the quarter, the Company received a net federal excise tax refund of $4.3 million, which is included in other operating income and $0.8 million of interest income related to the refund, which is included in net interest expense. The Company also recorded $4.0 million in other income related to a legal settlement receivable and a $1.0 million impairment of a minority investment in a development stage venture.

    2024 Outlook

    Management expects full-year 2024 adjusted EBITDA to be $95 to $100 million. This excludes any contribution from our CDS business which contributed a little over $2 million of EBITDA in FY 2023.

    Creative Distribution Solutions ("CDS") (15% of total net sales in the quarter)

    For the fourth quarter, CDS net sales were $14.1 million, gross profit was $3.1 million, and gross margin was 22.4%.

    Earnings Conference Call

    As previously disclosed, a conference call with the investment community to review TPB's financial results has been scheduled for 10:00 a.m. Eastern on Wednesday, February 28, 2024. Investment community participants should dial in 10 minutes ahead of time using the toll-free number 888-330-2502 (international participants should call 240-789-2713), and follow the audio prompts after typing in the event ID: 6640134. A live listen-only webcast of the call will be available on the Events and Presentations section of the investor relations portion of the Company website (www.turningpointbrands.com). A replay of the webcast will be available on the site two hours following the call.

    Non-GAAP Financial Measures

    In addition to financial measures prepared in accordance with generally accepted accounting principles in the United States (GAAP), this press release includes certain non-GAAP financial measures including EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Adjusted Operating Income (Loss) and Free Cash Flow. A reconciliation of these non-GAAP financial measures accompanies this release.

    About Turning Point Brands, Inc.

    Turning Point Brands (NYSE:TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients through its iconic Zig-Zag® and Stoker's® brands. TPB's products are available in more than 215,000 retail outlets in North America, and on sites such as www.zigzag.com. For the latest news and information about TPB and its brands, please visit www.turningpointbrands.com.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intend," "plan" and "will" or, in each case, their negative, or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. As a result, these statements are not guarantees of future performance and actual events may differ materially from those expressed in or suggested by the forward-looking statements. Any forward-looking statement made by TPB in this press release, its reports filed with the Securities and Exchange Commission (the "SEC") and other public statements made from time-to-time speak only as of the date made. New risks and uncertainties come up from time to time, and it is impossible for TPB to predict or identify all such events or how they may affect it. TPB has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. Factors that could cause these differences include, but are not limited to those included it the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed by the Company with the SEC. These statements constitute the Company's cautionary statements under the Private Securities Litigation Reform Act of 1995.

    Financial Statements Follow:

    Turning Point Brands, Inc.
    Consolidated Statements of Income
    (dollars in thousands except share data)
    (unaudited)

    Three Months Ended

    December 31,

     

    2023

     

     

     

    2022

     

    Net sales

    $

    97,120

     

    $

    103,392

     

    Cost of sales

     

    46,596

     

     

    53,829

     

    Gross profit

     

    50,524

     

     

    49,563

     

    Selling, general, and administrative expenses

     

    30,916

     

     

    31,245

     

    Other operating income, net

     

    (4,345

    )

     

    -

     

    Operating income

     

    23,953

     

     

    18,318

     

    Interest expense, net

     

    2,632

     

     

    4,382

     

    Investment loss

     

    934

     

     

    7,229

     

    Other income

     

    (4,000

    )

     

    -

     

    Goodwill and intangible impairment loss

     

    -

     

     

    27,566

     

    Loss (gain) on extinguishment of debt

     

    194

     

     

    (885

    )

    Income (loss) before income taxes

     

    24,193

     

     

    (19,974

    )

    Income tax expense (benefit)

     

    14,328

     

     

    (3,857

    )

    Consolidated net income (loss)

     

    9,865

     

     

    (16,117

    )

    Net (loss) income attributable to non-controlling interest

     

    (244

    )

     

    200

     

    Net income (loss) attributable to Turning Point Brands, Inc.

    $

    10,109

     

    $

    (16,317

    )

     
    Basic income (loss) per common share:
    Net income (loss) attributable to Turning Point Brands, Inc.

    $

    0.57

     

    $

    (0.93

    )

    Diluted income (loss) per common share:
    Net income (loss) attributable to Turning Point Brands, Inc.

    $

    0.53

     

    $

    (0.93

    )

    Weighted average common shares outstanding:
    Basic

     

    17,604,313

     

     

    17,530,278

     

    Diluted

     

    20,153,157

     

     

    17,530,278

     

     
    Supplemental disclosures of statement of income information:
    Excise tax expense

    $

    5,137

     

    $

    5,771

     

    FDA fees

    $

    138

     

    $

    158

     

    Turning Point Brands, Inc.
    Consolidated Statements of Income
    (dollars in thousands except share data)
    (unaudited)

    For the year ended

    December 31,

     

    2023

     

     

     

    2022

     

    Net sales

    $

    405,393

     

    $

    415,013

     

    Cost of sales

     

    202,152

     

     

    209,475

     

    Gross profit

     

    203,241

     

     

    205,538

     

    Selling, general, and administrative expenses

     

    125,009

     

     

    130,024

     

    Other operating income, net

     

    (4,345

    )

     

    -

     

    Operating income

     

    82,577

     

     

    75,514

     

    Interest expense, net

     

    14,645

     

     

    19,524

     

    Investment loss

     

    11,914

     

     

    13,303

     

    Other income

     

    (4,000

    )

     

    -

     

    Goodwill and intangible impairment loss

     

    -

     

     

    27,566

     

    Gain on extinguishment of debt

     

    (1,664

    )

     

    (885

    )

    Income before income taxes

     

    61,682

     

     

    16,006

     

    Income tax expense

     

    23,901

     

     

    4,849

     

    Consolidated net income

     

    37,781

     

     

    11,157

     

    Net loss attributable to non-controlling interest

     

    (681

    )

     

    (484

    )

    Net income attributable to Turning Point Brands, Inc.

    $

    38,462

     

    $

    11,641

     

     
    Basic income per common share:
    Net income attributable to Turning Point Brands, Inc.

    $

    2.19

     

    $

    0.65

     

    Diluted income per common share:
    Net income attributable to Turning Point Brands, Inc.

    $

    2.01

     

    $

    0.64

     

    Weighted average common shares outstanding:
    Basic

     

    17,578,270

     

     

    17,899,794

     

    Diluted

     

    20,467,406

     

     

    18,055,015

     

     
    Supplemental disclosures of statement of income information:
    Excise tax expense

    $

    20,575

     

    $

    23,274

     

    FDA fees

    $

    586

     

    $

    623

     

    Turning Point Brands, Inc.
    Consolidated Balance Sheets
    (dollars in thousands except share data)
    (unaudited)

    December 31,

    ASSETS

     

    2023

     

     

     

    2022

     

    Current assets:
    Cash

    $

    117,886

     

    $

    106,403

     

    Accounts receivable, net of allowances of $78 in 2023 and $114 in 2022

     

    9,989

     

     

    8,377

     

    Inventories, net

     

    98,960

     

     

    119,915

     

    Other current assets

     

    40,781

     

     

    22,959

     

    Total current assets

     

    267,616

     

     

    257,654

     

    Property, plant, and equipment, net

     

    25,300

     

     

    22,788

     

    Deferred income taxes

     

    1,468

     

     

    8,443

     

    Right of use assets

     

    11,480

     

     

    12,465

     

    Deferred financing costs, net

     

    2,450

     

     

    282

     

    Goodwill

     

    136,250

     

     

    136,253

     

    Other intangible assets, net

     

    80,942

     

     

    83,592

     

    Master Settlement Agreement (MSA) escrow deposits

     

    28,684

     

     

    27,980

     

    Other assets

     

    15,166

     

     

    22,649

     

    Total assets

    $

    569,356

     

    $

    572,106

     

     
    LIABILITIES AND STOCKHOLDERS' EQUITY
    Current liabilities:
    Accounts payable

    $

    8,407

     

    $

    8,355

     

    Accrued liabilities

     

    33,635

     

     

    33,001

     

    Current portion of long-term debt, net

     

    58,294

     

     

    -

     

    Other current liabilities

     

    -

     

     

    20

     

    Total current liabilities

     

    100,336

     

     

    41,376

     

    Notes payable and long-term debt

     

    307,064

     

     

    406,757

     

    Lease liabilities

     

    9,950

     

     

    10,593

     

    Total liabilities

     

    417,350

     

     

    458,726

     

     
    Commitments and contingencies
     
    Stockholders' equity:
    Preferred stock; $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-

     

    -

     

     

    -

     

    Common stock, voting, $0.01 par value; authorized shares, 190,000,000; 19,922,137 issued shares,
    17,605,677 outstanding shares at December 31, 2023, and 19,801,623 issued shares, 17,485,163
    outstanding shares at December 31, 2022

     

    199

     

     

    198

     

    Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000;
    issued and outstanding shares -0-

     

    -

     

     

    -

     

    Additional paid-in capital

     

    119,075

     

     

    113,242

     

    Cost of repurchased common stock
    (2,316,460 shares at December 31, 2023 and 2022)

     

    (78,093

    )

     

    (78,093

    )

    Accumulated other comprehensive loss

     

    (2,648

    )

     

    (2,393

    )

    Accumulated earnings

     

    112,443

     

     

    78,691

     

    Non-controlling interest

     

    1,030

     

     

    1,735

     

    Total stockholders' equity

     

    152,006

     

     

    113,380

     

    Total liabilities and stockholders' equity

    $

    569,356

     

    $

    572,106

     

    Turning Point Brands, Inc.
    Consolidated Statements of Cash Flows
    (dollars in thousands)
    (unaudited)

    For the Year Ended

    December 31,

     

    2023

     

     

     

    2022

     

    Cash flows from operating activities:
    Consolidated net income

    $

    37,781

     

    $

    11,157

     

    Adjustments to reconcile net income to net cash provided by operating activities:
    Gain on extinguishment of debt

     

    (1,664

    )

     

    (885

    )

    Loss (gain) on sale of property, plant, and equipment

     

    90

     

     

    (9

    )

    Loss on goodwill impairment

     

    -

     

     

    25,585

     

    Loss on intangible asset impairment

     

    -

     

     

    1,982

     

    Gain on insurance recovery of inventory loss

     

    (15,181

    )

     

    -

     

    Loss on investments

     

    12,177

     

     

    13,570

     

    Depreciation and other amortization expense

     

    3,262

     

     

    3,388

     

    Amortization of other intangible assets

     

    3,096

     

     

    1,911

     

    Amortization of deferred financing costs

     

    2,445

     

     

    2,576

     

    Deferred income tax expense (benefit)

     

    7,024

     

     

    (6,506

    )

    Stock compensation expense

     

    6,561

     

     

    5,273

     

    Noncash lease income

     

    (82

    )

     

    (29

    )

    Gain on MSA escrow deposits

     

    -

     

     

    (54

    )

    Changes in operating assets and liabilities:
    Accounts receivable

     

    (1,609

    )

     

    (2,103

    )

    Inventories

     

    20,977

     

     

    (32,653

    )

    Other current assets

     

    (3,533

    )

     

    4,581

     

    Other assets

     

    (4,835

    )

     

    420

     

    Accounts payable

     

    (14

    )

     

    1,240

     

    Accrued liabilities and other

     

    386

     

     

    830

     

    Net cash provided by operating activities

     

    66,881

     

     

    30,273

     

     
    Cash flows from investing activities:
    Capital expenditures

    $

    (5,707

    )

    $

    (7,685

    )

    Payments for investments

     

    (202

    )

     

    (1,000

    )

    Restricted cash, MSA escrow deposits

     

    -

     

     

    (10,170

    )

    Proceeds on the sale of property, plant and equipment

     

    3

     

     

    62

     

    Net cash used in investing activities

     

    (5,906

    )

     

    (18,793

    )

    Turning Point Brands, Inc.
    Consolidated Statements of Cash Flows (Cont.)
    (dollars in thousands)
    (unaudited)

    For the Year Ended

    December 31,

     

    2023

     

     

     

    2022

     

    Cash flows from financing activities:
    Convertible Senior Notes repurchased

     

    (41,794

    )

     

    (9,000

    )

    Proceeds from call options

     

    114

     

     

    51

     

    Payment of dividends

     

    (4,497

    )

     

    (4,250

    )

    Payments of financing costs

     

    (2,437

    )

     

    -

     

    Exercise of options

     

    450

     

     

    504

     

    Redemption of options

     

    (346

    )

     

    (155

    )

    Redemption of restricted stock units

     

    (995

    )

     

    (1,229

    )

    Common stock repurchased

     

    -

     

     

    (29,224

    )

    Net cash used in financing activities

    $

    (49,505

    )

    $

    (43,303

    )

     
    Net increase (decrease) in cash

    $

    11,470

     

    $

    (31,823

    )

    Effect of foreign currency translation on cash

    $

    13

     

    $

    (320

    )

     
    Cash, beginning of period:
    Unrestricted

    $

    106,403

     

    $

    128,320

     

    Restricted

     

    4,929

     

     

    15,155

     

    Total cash at beginning of period

    $

    111,332

     

    $

    143,475

     

     
     
    Unrestricted

    $

    117,886

     

    $

    106,403

     

    Restricted

     

    4,929

     

     

    4,929

     

    Total cash at end of period

    $

    122,815

     

    $

    111,332

     

    Non-GAAP Financial Measures

    To supplement our financial information presented in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, we use non-U.S. GAAP financial measures, including EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Adjusted Gross Profit and Adjusted Operating Income (Loss). We believe Adjusted EBITDA provides useful information to management and investors regarding certain financial and business trends relating to our financial condition and results of operations. Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Adjusted Gross Profit and Adjusted Operating Income (Loss) are used by management to compare our performance to that of prior periods for trend analyses and planning purposes and are presented to our board of directors. We believe that EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS, Adjusted Gross Profit and Adjusted Operating Income (Loss) are appropriate measures of operating performance because they eliminate the impact of expenses that do not relate to business performance.

    We define "EBITDA" as net income (loss) before interest expense, gain (loss) on extinguishment of debt, provision for (benefit from) income taxes, depreciation and amortization. We define "Adjusted EBITDA" as net income before interest expense, gain (loss) on extinguishment of debt, provision for (benefit from) income taxes, depreciation, amortization, other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Net Income" as net income excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Diluted EPS" as diluted earnings per share excluding items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Gross Profit: as gross profit excluding other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Adjusted Operating Income (Loss)" as operating income excluding other non-cash items and other items that we do not consider ordinary course in our evaluation of ongoing operating performance. We define "Free Cash Flow" as "Net Cash provided by operating activities" less Capital expenditures.

    Non-U.S. GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with U.S. GAAP. EBITDA, Adjusted Net Income, Adjusted EBITDA Adjusted Diluted EPS, Adjusted Gross Profit and Adjusted Operating Income (Loss) exclude significant expenses that are required by U.S. GAAP to be recorded in our financial statements and are subject to inherent limitations. In addition, other companies in our industry may calculate these non-U.S. GAAP measure differently than we do or may not calculate it at all, limiting their usefulness as comparative measures.

    In accordance with SEC rules, we have provided, in the supplemental information attached, a reconciliation of the non-GAAP measures to the next directly comparable GAAP measures.

    Schedule A
     
     
     
    Turning Point Brands, Inc.
    Reconciliation of GAAP Net Income (Loss) to Adjusted EBITDA
    (dollars in thousands)
    (unaudited)

    Three Months Ended

    December 31,

     

    2023

     

     

     

    2022

     

    Net income (loss) attributable to Turning Point Brands, Inc.

    $

    10,109

     

    $

    (16,317

    )

    Add:
    Interest expense, net

     

    2,632

     

     

    4,382

     

    Loss (gain) on extinguishment of debt

     

    194

     

     

    (885

    )

    Income tax expense (benefit)

     

    14,328

     

     

    (3,857

    )

    Depreciation expense

     

    804

     

     

    777

     

    Amortization expense

     

    851

     

     

    538

     

    EBITDA

    $

    28,918

     

    $

    (15,362

    )

    Components of Adjusted EBITDA
    Corporate and CDS restructuring (a)

     

    199

     

     

    1,825

     

    ERP/CRM (b)

     

    138

     

     

    336

     

    Stock options, restricted stock, and incentives expense (c)

     

    1,901

     

     

    1,170

     

    Transactional expenses and strategic initiatives(d)

     

    3

     

     

    12

     

    FDA PMTA (e)

     

    1,003

     

     

    289

     

    Non-cash asset impairment (f)

     

    1,015

     

     

    34,836

     

    FET refund (g)

     

    (4,345

    )

     

    -

     

    Legal settlement (h)

     

    (4,000

    )

     

    -

     

    Adjusted EBITDA

    $

    24,832

     

    $

    23,106

     

    (a) Represents costs associated with corporate and CDS restructuring, including severance.
    (b) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.
    (c) Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units.
    (d) Represents the fees incurred for transaction expenses.
    (e) Represents costs associated with applications related to FDA premarket tobacco product application ("PMTA").
    (f) Represents impairment of goodwill, intangible and investment assets.
    (g) Represents federal excise tax refund included in other operating income, net.
    (h) Represents other income from litigation settlement.
    Schedule A
     
     
     
    Turning Point Brands, Inc.
    Reconciliation of GAAP Net Income to Adjusted EBITDA
    (dollars in thousands)
    (unaudited)

    For the Year Ended

    December 31,

     

    2023

     

     

     

    2022

     

    Net income attributable to Turning Point Brands, Inc.

    $

    38,462

     

    $

    11,641

     

    Add:
    Interest expense, net

     

    14,645

     

     

    19,524

     

    Gain on extinguishment of debt

     

    (1,664

    )

     

    (885

    )

    Income tax expense

     

    23,901

     

     

    4,849

     

    Depreciation expense

     

    3,121

     

     

    3,388

     

    Amortization expense

     

    3,237

     

     

    1,911

     

    EBITDA

    $

    81,702

     

    $

    40,428

     

    Components of Adjusted EBITDA
    Corporate and CDS restructuring (a)

     

    389

     

     

    3,444

     

    ERP/CRM (b)

     

    552

     

     

    1,962

     

    Stock options, restricted stock, and incentives expense (c)

     

    6,561

     

     

    5,273

     

    Transactional expenses and strategic initiatives (d)

     

    165

     

     

    801

     

    FDA PMTA (e)

     

    2,098

     

     

    4,554

     

    Non-cash asset impairment (f)

     

    12,177

     

     

    41,136

     

    FET refund (g)

     

    (4,345

    )

     

    -

     

    Legal settlement (h)

     

    (4,000

    )

     

    -

     

    Adjusted EBITDA

    $

    95,299

     

    $

    97,598

     

    (a) Represents costs associated with corporate and CDS restructuring, including severance.
    (b) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses.
    (c) Represents non-cash stock options, restricted stock, incentives expense and Solace performance stock units.
    (d) Represents the fees incurred for transaction expenses.
    (e) Represents costs associated with applications related to FDA premarket tobacco product application ("PMTA").
    (f) Represents impairment of goodwill, intangible and investment assets.
    (g) Represents federal excise tax refund included in other operating income, net.
    (h) Represents other income from litigation settlement.
    Schedule B
     
    Turning Point Brands, Inc.
    Reconciliation of GAAP Net Income (Loss) to Adjusted Net Income and Diluted EPS to Adjusted Diluted EPS
    (dollars in thousands except share data)
    (unaudited)

    Three Months Ended

     

    Three Months Ended

    December 31, 2023

     

    December 31, 2022

    Net Income

     

    Diluted EPS

     

    Net Income (Loss)

     

    Diluted EPS

    GAAP

    $

    10,109

     

    $

    0.53

     

    $

    (16,317

    )

    $

    (0.93

    )

    Anti-dilutive impact (a)

     

    -

     

     

    0.00

     

     

    -

     

     

    0.20

     

    Gain on extinguishment of debt (b)

     

    146

     

     

    0.01

     

     

    (714

    )

     

    (0.03

    )

    Corporate and CDS restructuring (c)

     

    150

     

     

    0.01

     

     

    1,473

     

     

    0.07

     

    ERP/CRM (d)

     

    104

     

     

    0.01

     

     

    271

     

     

    0.01

     

    Stock options, restricted stock, and incentives expense (e)

     

    1,434

     

     

    0.07

     

     

    944

     

     

    0.05

     

    Transactional expenses and strategic initiatives (f)

     

    2

     

     

    0.00

     

     

    10

     

     

    0.00

     

    FDA PMTA (g)

     

    757

     

     

    0.04

     

     

    233

     

     

    0.01

     

    Non-cash asset impairment (h)

     

    766

     

     

    0.04

     

     

    28,109

     

     

    1.35

     

    FET refund (i)

     

    (3,843

    )

     

    (0.19

    )

     

    -

     

     

    -

     

    Legal settlement (j)

     

    (3,017

    )

     

    (0.15

    )

     

    -

     

     

    -

     

    Deferred tax valuation allowance (k)

     

    8,383

     

     

    0.42

     

     

    -

     

     

    -

     

    Impact of quarterly tax items to effective tax rate (l)

     

    311

     

     

    0.02

     

     

    (804

    )

     

    (0.04

    )

    Adjusted

    $

    15,302

     

    $

    0.79

     

    $

    13,205

     

    $

    0.69

     

    Total may not foot due to rounding
    Note: Quarterly tax rate used excludes impact of deferred tax valuation allowance.
    (a) Represents dilution of options and debt conversion that is anti-dilutive and not included for GAAP.
    (b) Represents gain on extinguishment of debt tax effected at the quarterly tax rate.
    (c) Represents costs associated with corporate and CDS restructuring, including severance tax effected at the quarterly tax rate.
    (d) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses tax effected at the quarterly tax rate.
    (e) Represents non-cash stock options, restricted stock, incentives expense and Solace PRSUs tax effected at the quarterly tax rate.
    (f) Represents the fees incurred for transaction expenses tax effected at the quarterly tax rate.
    (g) Represents costs associated with applications related to the FDA PMTA tax effected at the quarterly tax rate.
    (h) Represents impairment of goodwill, intangible and investment assets tax effected at the quarterly tax rate.
    (i) Represents federal excise tax refund and related interest income effected at the quarterly tax rate.
    (j) Represents receivable from legal settlement tax effected at the quarterly tax rate.
    (k) Represents deferred tax valuation allowance.
    (l) Represents adjustment from quarterly tax rate to annual projected tax rate of 23% in 2023 and 2022.
    Schedule B
     
    Turning Point Brands, Inc.
    Reconciliation of GAAP Net Income to Adjusted Net Income and Diluted EPS to Adjusted Diluted EPS
    (dollars in thousands except share data)
    (unaudited)
    For the Year Ended For the Year Ended
    December 31, 2023 December 31, 2022
    Net Income Diluted EPS Net Income Diluted EPS
    GAAP

    $

    38,462

     

    $

    2.01

     

    $

    11,641

     

    $

    0.64

     

    Anti-dilutive impact (a)

     

    -

     

     

    (0.00

    )

     

    -

     

     

    0.09

     

    Gain on extinguishment of debt (b)

     

    (1,245

    )

     

    (0.06

    )

     

    (617

    )

     

    (0.03

    )

    Corporate and CDS restructuring (c)

     

    291

     

     

    0.01

     

     

    2,401

     

     

    0.11

     

    ERP/CRM (d)

     

    413

     

     

    0.02

     

     

    1,368

     

     

    0.06

     

    Stock options, restricted stock, and incentives expense (e)

     

    4,910

     

     

    0.24

     

     

    3,676

     

     

    0.17

     

    Transactional expenses and strategic initiatives (f)

     

    123

     

     

    0.01

     

     

    558

     

     

    0.03

     

    FDA PMTA (g)

     

    1,570

     

     

    0.08

     

     

    3,174

     

     

    0.15

     

    Non-cash asset impairment (h)

     

    9,114

     

     

    0.45

     

     

    28,674

     

     

    1.35

     

    FET refund (i)

     

    (3,813

    )

     

    (0.19

    )

     

    -

     

     

    -

     

    Legal settlement (j)

     

    (2,994

    )

     

    (0.15

    )

     

    -

     

     

    -

     

    Deferred tax valuation allowance (k)

     

    8,383

     

     

    0.41

     

     

    -

     

     

    -

     

    Impact of annual tax items to effective tax rate (l)

     

    1,587

     

     

    0.08

     

     

    5,309

     

     

    0.25

     

    Adjusted

    $

    56,802

     

    $

    2.91

     

    $

    56,183

     

    $

    2.83

     

    Total may not foot due to rounding
    Note: Annual tax rate used excludes impact of deferred tax valuation allowance.
    (a) Represents dilution of debt conversion that is anti-dilutive and not included for GAAP.
    (b) Represents gain on extinguishment of debt tax effected at the annual tax rate.
    (c) Represents costs associated with corporate and CDS restructuring, including severance tax effected at the annual tax rate.
    (d) Represents cost associated with scoping and mobilization of new ERP and CRM systems and cost of duplicative ERP licenses tax effected at the annual tax rate.
    (e) Represents non-cash stock options, restricted stock, incentives expense and Solace PRSUs tax effected at the annual tax rate.
    (f) Represents the fees incurred for transaction expenses tax effected at the annual tax rate.
    (g) Represents costs associated with applications related to the FDA PMTA tax effected at the annual tax rate.
    (h) Represents impairment of goodwill, intangible and investment assets tax effected at the annual tax rate.
    (i) Represents federal excise tax refund and related interest income effected at the annual tax rate.
    (j) Represents receivable from legal settlement tax effected at the annual tax rate.
    (k) Represents deferred tax valuation allowance.
    (l) Represents adjustment from annual tax rate to annual projected tax rate of 23% in 2023 and 2022.
    Schedule C
     
    Turning Point Brands, Inc.
    Reconciliation of GAAP Operating Income (Loss) to Adjusted Operating Income (Loss)
    (dollars in thousands)
    (unaudited)

    Consolidated

     

    Zig-Zag

     

    Stoker's

     

    Creative Distribution Solutions

    4th Quarter

     

    4th Quarter

     

    4th Quarter

     

    4th Quarter

     

    4th Quarter

     

    4th Quarter

     

    4th Quarter

     

    4th Quarter

     

    2023

     

     

     

    2022

     

     

    2023

     

     

    2022

     

     

    2023

     

     

     

    2022

     

     

    2023

     

     

     

    2022

     
    Net sales

    $

    97,120

     

    $

    103,392

    $

    45,092

    $

    46,444

    $

    37,976

     

    $

    32,010

    $

    14,052

     

    $

    24,938

     
    Gross profit

    $

    50,524

     

    $

    49,563

    $

    25,499

    $

    25,768

    $

    21,883

     

    $

    17,210

    $

    3,142

     

    $

    6,585

     
    Operating income (loss)

    $

    23,953

     

    $

    18,318

    $

    20,968

    $

    17,362

    $

    12,533

     

    $

    12,794

    $

    (646

    )

    $

    134

    Adjustments:
    Transactional expenses and strategic initiatives

     

    3

     

     

    12

     

    -

     

    -

     

    -

     

     

    -

     

    -

     

     

    -

    FDA PMTA

     

    1,003

     

     

    289

     

    -

     

    -

     

    -

     

     

    -

     

    -

     

     

    -

    Corporate and CDS restructuring

     

    199

     

     

    1,825

     

    -

     

    -

     

    -

     

     

    -

     

    -

     

     

    -

    ERP/CRM

     

    138

     

     

    336

     

    -

     

    -

     

    -

     

     

    -

     

    -

     

     

    -

    FET refund

     

    (4,345

    )

     

    -

     

    -

     

    -

     

    (4,345

    )

     

    -

     

    -

     

     

    -

    Adjusted operating income (loss)

    $

    20,951

     

    $

    20,780

    $

    20,968

    $

    17,362

    $

    8,188

     

    $

    12,794

    $

    (646

    )

    $

    134

    Schedule C
     
    Turning Point Brands, Inc.
    Reconciliation of GAAP Operating Income (Loss) to Adjusted Operating Income (Loss)
    (dollars in thousands)
    (unaudited)

    Consolidated

     

    Zig-Zag

     

    Stoker's

     

    Creative Distribution Solutions

    YTD

     

    YTD

     

    YTD

     

    YTD

     

    YTD

     

    YTD

     

    YTD

     

    YTD

     

    2023

     

     

     

    2022

     

     

    2023

     

     

    2022

     

     

    2023

     

     

     

    2022

     

     

    2023

     

     

     

    2022

     
    Net sales

    $

    405,393

     

    $

    415,013

    $

    180,455

    $

    190,403

    $

    144,609

     

    $

    130,826

    $

    80,329

     

    $

    93,784

     
    Gross profit

    $

    203,241

     

    $

    205,538

    $

    101,055

    $

    106,576

    $

    81,887

     

    $

    71,254

    $

    20,299

     

    $

    27,708

     
    Operating income (loss)

    $

    82,577

     

    $

    75,514

    $

    68,280

    $

    73,342

    $

    58,180

     

    $

    53,331

    $

    (383

    )

    $

    1,506

    Adjustments:
    Transactional expenses and strategic initiatives

     

    165

     

     

    801

     

    -

     

    -

     

    -

     

     

    -

     

    -

     

     

    -

    FDA PMTA

     

    2,098

     

     

    4,554

     

    -

     

    -

     

    -

     

     

    -

     

    -

     

     

    -

    Corporate and CDS restructuring

     

    389

     

     

    3,444

     

    -

     

    -

     

    -

     

     

    -

     

    190

     

     

    -

    ERP/CRM

     

    552

     

     

    1,962

     

    -

     

    -

     

    -

     

     

    -

     

    -

     

     

    -

    FET refund

     

    (4,345

    )

     

    -

     

    -

     

    -

     

    (4,345

    )

     

    -

     

    -

     

     

    -

    Adjusted operating income (loss)

    $

    81,436

     

    $

    86,275

    $

    68,280

    $

    73,342

    $

    53,835

     

    $

    53,331

    $

    (193

    )

    $

    1,506

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240228612689/en/

    Get the next $TPB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TPB

    DatePrice TargetRatingAnalyst
    8/1/2025Hold
    Needham
    3/3/2025$80.00Buy
    Alliance Global Partners
    11/14/2024$65.00Outperform
    Oppenheimer
    9/19/2024$50.00Buy
    ROTH MKM
    6/6/2023$28.00Buy
    The Benchmark Company
    10/10/2022$28.00 → $22.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $TPB
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Turning Point Brands Inc.

    SCHEDULE 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    2/12/26 11:15:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands Inc. filed SEC Form 8-K: Other Events, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Turning Point Brands, Inc. (0001290677) (Filer)

    11/5/25 5:12:09 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    SEC Form 424B5 filed by Turning Point Brands Inc.

    424B5 - Turning Point Brands, Inc. (0001290677) (Filer)

    11/5/25 5:08:01 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Turning Point Brands

    Needham initiated coverage of Turning Point Brands with a rating of Hold

    8/1/25 8:13:43 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Alliance Global Partners initiated coverage on Turning Point Brands with a new price target

    Alliance Global Partners initiated coverage of Turning Point Brands with a rating of Buy and set a new price target of $80.00

    3/3/25 8:28:08 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Oppenheimer initiated coverage on Turning Point Brands with a new price target

    Oppenheimer initiated coverage of Turning Point Brands with a rating of Outperform and set a new price target of $65.00

    11/14/24 7:57:59 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Strategy Officer De Plano Lorenzo bought $127,200 worth of shares (4,000 units at $31.80), increasing direct ownership by 13% to 34,896 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/18/24 5:01:10 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Chief Revenue Officer Frein Summer bought $69,970 worth of shares (2,260 units at $30.96), increasing direct ownership by 15% to 17,203 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    6/14/24 6:50:56 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    De Plano Lorenzo bought $420,753 worth of shares (15,043 units at $27.97), increasing direct ownership by 92% to 31,375 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    3/18/24 9:17:02 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Turning Point Brands Increases Common Stock Dividend

    The Board of Directors of Turning Point Brands, Inc. ("TPB") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients, declared a regular quarterly dividend of $0.08 per common share. This is a 7% increase over the regular quarter dividend declared in November 2025. The dividend is payable on April 10, 2026 to shareholders of record on the close of business on March 20, 2026. About Turning Point Brands, Inc. Turning Point Brands, Inc. (NYSE:TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with ac

    2/25/26 4:37:00 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    FRE® Nicotine Pouches Partners with Taylor Reimer Racing to Power Performance On and Off the Track

    FRE commits to fueling focus across ARCA Menards Series Events in Alabama, Michigan, Minnesota and Arizona FRE® Nicotine Pouches today announced a partnership with Taylor Reimer Racing as the Official Nicotine Sponsor across four marquee races during the 2026 ARCA Menards Series. FRE will play a leading role in supporting Reimer as she competes in some of the sport's most high-stakes environments, aligning the brand with one of motorsports' most exciting rising drivers to champion focus, momentum, and performance under pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224795966/en/FRE will play a leading role in supp

    2/24/26 9:00:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    FRE Lush 15mg Mega Pack Named 2026 Product of the Year USA Award Winner

    40,000 American Shoppers Voted FRE Lush 15mg Mega Pack as Most Innovative Product in the Smokeless Tobacco Category of 2026 FRE® Nicotine Pouches, a bold, freshness-forward nicotine pouch brand designed by users for users, has been recognized as a winner of the 2026 Product of the Year USA Awards. Determined through a national study of 40,000 American shoppers conducted in partnership with Kantar, a global leader in consumer research, Product of the Year is the largest consumer-voted awards program focused on product innovation. The FRE Lush 15mg Mega Pack is awarded the highly acclaimed honor of best product within the Smokeless Tobacco category. This press release features multimedia.

    2/20/26 10:00:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wexler Lawrence covered exercise/tax liability with 425 shares, decreasing direct ownership by 0.15% to 283,291 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    1/6/26 8:54:48 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Sr VP, General Counsel Cushman Brittani covered exercise/tax liability with 193 shares, decreasing direct ownership by 0.56% to 34,081 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    1/6/26 8:52:20 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    President and CEO Purdy Graham covered exercise/tax liability with 368 shares, decreasing direct ownership by 0.16% to 227,098 units (SEC Form 4)

    4 - Turning Point Brands, Inc. (0001290677) (Issuer)

    1/6/26 8:50:38 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/14/24 12:37:11 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/8/24 4:32:30 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Turning Point Brands Inc.

    SC 13G/A - Turning Point Brands, Inc. (0001290677) (Subject)

    11/8/24 12:58:51 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Leadership Updates

    Live Leadership Updates

    View All

    Turning Point Brands Appoints Andrew Flynn as Chief Financial Officer

    Turning Point Brands, Inc. ("TPB" or the "Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, announced today the appointment Andrew Flynn as the Company's new Chief Financial Officer, effective on or before April 1, 2024. Mr. Flynn is replacing Louie Reformina, who will step down to pursue other opportunities. Prior to joining Turning Point Brands, Mr. Flynn served as the CFO of Connected Cannabis Co. where he was responsible for bringing sustained profitable growth, expanding geographically and recapitalizing the company. In this role Mr. Flynn operationalized and

    3/11/24 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Kaival Brands Appoints James W. Dobbins as Senior Vice President, General Counsel

    GRANT-VALKARIA, Fla., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) ("Kaival Brands," the "Company," or "we"), today announced that it has appointed James W. Dobbins as General Counsel effective December 5, 2023. Barry Hopkins, Executive Chairman of Kaival Brands, said, "James Dobbins has extensive experience advising companies on a breadth of legal matters, and importantly, he also has a deep, relevant understanding of industry business operations, including corporate governance, M&A, international sourcing, and compliance matters. Along with an anticipated reduction in legal expenses, we are thrilled to welcome James to guide and assist our execut

    12/7/23 8:30:00 AM ET
    $KAVL
    $TPB
    Other Consumer Services
    Consumer Discretionary
    Tobacco

    Kaival Brands Appoints New Chief Executive Officer and Chief Financial Officer

    Former Turning Points Brands executive Thomas Metzler brings decades of finance and operational industry experience to Kaival Brands as its new Chief Financial Officer Current President & Chief Operating Officer Eric Mosser promoted to Chief Executive Officer GRANT-VALKARIA, Fla., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) ("Kaival Brands," the "Company" or "we," "our" or similar terms), a company focused on incubating and commercializing innovative products into mature and dominant brands, with a current focus on the distribution of electronic nicotine delivery systems (ENDS), which are intended for adults 21 and over, today announced the appoi

    8/3/23 8:15:00 AM ET
    $KAVL
    $TPB
    Other Consumer Services
    Consumer Discretionary
    Tobacco

    $TPB
    Financials

    Live finance-specific insights

    View All

    Turning Point Brands Increases Common Stock Dividend

    The Board of Directors of Turning Point Brands, Inc. ("TPB") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients, declared a regular quarterly dividend of $0.08 per common share. This is a 7% increase over the regular quarter dividend declared in November 2025. The dividend is payable on April 10, 2026 to shareholders of record on the close of business on March 20, 2026. About Turning Point Brands, Inc. Turning Point Brands, Inc. (NYSE:TPB) is a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with ac

    2/25/26 4:37:00 PM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands to Host Q4 and Fiscal Year 2025 Conference Call

    Turning Point Brands, Inc. (NYSE:TPB) announced the date and time for its conference call to review fourth quarter and fiscal year 2025 results. The conference call will be on Monday, March 2, 2026 at 9 a.m. Eastern. Interested analysts and professional investors can register and participate through one of these call-in numbers: (800) 715-9871 (U.S., toll-free) (646) 307-1963 (International) Event ID: 6640134 Participants should dial in at least 10 minutes in advance and follow the audio prompts after typing in the Event ID. The call will also be broadcast live as a listen-only webcast from the investor relations section of the company's website at http://www.turningpointbrands.com/in

    2/18/26 8:00:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    Turning Point Brands Announces Third Quarter 2025 Results

    Consolidated Net Sales for Q3 2025 increased 31.2% year-over-year to $119.0 million Modern Oral Net Sales for Q3 2025 increased 627.6% year-over-year to $36.7 million, accounting for 30.8% of total Company Net Sales Q3 2025 Adjusted EBITDA of $31.3 million, up 17.2% over prior year Company increasing 2025 Adjusted EBITDA guidance to $115.0 – 120.0 million (from $110.0 – 114.0 million) Company increasing full-year Modern Oral sales guidance to $125.0 – 130.0 million (from $100.0 – 110.0 million) Turning Point Brands, Inc. ("TPB" or the "Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consuma

    11/5/25 7:30:00 AM ET
    $TPB
    Tobacco
    Consumer Discretionary

    $TPB
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at Turning Point Brands Inc. on Jun 18 Indicate?

    On June 18, 2024, Turning Point Brands Inc. experienced a significant insider purchase when Chief Strategy Officer De Plano Lorenzo bought $127,200 worth of shares. This transaction involved the acquisition of 4,000 units at a price of $31.80 per unit, leading to an increase in his direct ownership by 13% to 34,896 units, as reported in the SEC Form 4. This move by an insider to increase their stake in the company is generally viewed as a positive signal by the market. Examining the recent insider activity at Turning Point Brands Inc., we can identify a few notable trades that occurred around the same time. On May 10, 2024, New insider Catsimatidis John A. Jr claimed ownership of 410,000 sh

    6/18/24 10:08:05 PM ET
    $TPB
    Tobacco
    Consumer Discretionary